Practice Easily Missed?

Late onset type 1 diabetes

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2827 (Published 30 April 2012) Cite this as: BMJ 2012;344:e2827
  1. Daniel Lasserson, senior clinical researcher1,
  2. Robin Fox, general practitioner2,
  3. Andrew Farmer, professor of general practice1
  1. 1University of Oxford, Department of Primary Care Health Sciences, Oxford OX1 2ET, UK
  2. 2The Health Centre, Bicester, UK
  1. Correspondence to: D Lasserson daniel.lasserson{at}phc.ox.ac.uk

A 41 year old man from an Indian family whose father had type 2 diabetes presented to his general practitioner with a four week history of increasing thirst and polyuria. He had not noticed any weight loss. Blood tests were arranged to confirm the diagnosis of diabetes. One week later, after having to push his car home, he began to feel exhausted and developed intermittent vomiting, which he attributed to exertion. Over the next two days he became more unwell, and the out of hours primary care service was contacted. He was reviewed urgently and admitted with diabetic ketoacidosis.

What is late onset type 1 diabetes?

A spectrum of autoimmune diabetes presents in adulthood, with type 1 diabetes characterised by the requirement of insulin at diagnosis to control glycaemia and prevent ketogenesis. Latent autoimmune diabetes of adulthood (LADA) also occurs but with much slower progression to requiring insulin after initial diagnosis.

How common is late onset type 1 diabetes?

  • In the 30–50 year age group, type 1 diabetes accounts for 13% of all new cases of diabetes1

  • Annual incidence is 15/100 000 in the 15–34 year age group, increasing by 2.8% annually,2 and is 7/100 000 in the 30–50 age group1

Why is it missed?

Similar rates of ketoacidosis are seen in patients with type 1 diabetes at diagnosis in adulthood and childhood,3 and diagnostic delay is thought to account for many presentations with ketoacidosis in children.4 Although the classic symptoms produced by hyperglycaemia are unlikely to be missed, there may be a delay in accurately identifying patients requiring insulin at diagnosis if there is a clinical resemblance to type …

Sign in

Subscribe